Titlebook: Biopharmaceutical Drug Design and Development; Susanna Wu-Pong,Yongyut Rojanasakul Book 19991st edition Humana Press 1999 antibody.biology

只看該作者 · 發(fā)表于 2025-3-26 21:00:54

Therapeutic Use of Recombinant Proteins,the immune system. These proteins act as hormones and can have their effects at sites distant from the point of secretion. Use of molecular biologic techniques to clone genes for the various cytokines, introduce them into bacteria, and purify the secreted proteins have now made these agents available for clinical use.

只看該作者 · 發(fā)表于 2025-3-27 02:28:51

只看該作者 · 發(fā)表于 2025-3-27 06:43:26

只看該作者 · 發(fā)表于 2025-3-27 13:02:07

只看該作者 · 發(fā)表于 2025-3-27 15:44:30

Bengt Anderberg,Myron L. Wolbarshtfewer resources than the pharmaceutical industry has required in the past (1). This chapter will focus on biotechnology product development specifically within the biotechnology industry. Because recombinant human protein therapeutics are the furthest advanced of the biotechnology products, this discussion will focus on proteins.

只看該作者 · 發(fā)表于 2025-3-27 21:06:10

只看該作者 · 發(fā)表于 2025-3-27 23:12:24

只看該作者 · 發(fā)表于 2025-3-28 04:09:12

只看該作者 · 發(fā)表于 2025-3-28 07:11:13

Book 19991st editionman existence. Imagine the excitement surround- ing the "penicillin project" and the subsequent rapid development of anti-infective agents that took place in the 1940s and 1950s. Fast for- ward to the world today and our ability to treat life-threatening infec- tions. This is but one small piece in

只看該作者 · 發(fā)表于 2025-3-28 10:52:05

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 23:34
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved